Literature DB >> 9724471

The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency.

A A Busuttil1, J A Goss, P Seu, T S Dulkanchainun, G S Yanni, S V McDiarmid, R W Busuttil.   

Abstract

The purpose of this study was to combine our clinical experience with a review of the literature to determine the value of orthotopic liver transplantation in the treatment of both boys and girls with ornithine transcarbamylase deficiency. Three boys younger than 1 year of age with symptomatic ornithine transcarbamylase deficiency (median age, 116 days; range, 40 to 223 days) underwent orthotopic liver transplantation. The patients' growth, developmental progress, ammonia levels, and amino acid levels were analyzed pre- and post-liver transplantation. The clinical courses of the respective patients and the treatment modalities used were compared with published reports from 1978 through 1997. The median follow-up period in these 3 patients was 3.2 years (range, 9 months to 5.2 years). Orthotopic liver transplantation restored normal urea production and stabilized ammonia levels within 24 hours of surgery (median serum ammonia level 24 hours post-liver replacement, 43 micromol/L; range, 30 to 66 micromol/L). After liver replacement, arginine synthesis was normalized; however, plasma citrulline levels remained less than normal in all patients. Linear growth was evaluated in all 3 patients at the time of the most recent follow-up; median z scores for patient height and weight were -2.16 and -1.16, respectively. Standardized intelligence tests showed that 2 of the 3 patients continue to perform at age-appropriate levels. The third child was developmentally delayed pretransplantation at 4 months of age on presentation and continues to perform in a below-average fashion. Orthotopic liver transplantation results in the restoration of normal urea production and serum ammonia levels in the boy suffering from symptomatic ornithine transcarbamylase deficiency. Serum arginine, but not citrulline, levels are normalized, probably because of the persistent intestinal mucosa defect. Patient growth is similar to that in infants undergoing liver transplantation for other causes. When liver transplantation is performed before cognitive impairment occurs, intellectual development is normal, because the risk of additional episodes of hyperammonemia is elevated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724471     DOI: 10.1002/lt.500040504

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  9 in total

Review 1.  Ornithine carbamoyltransferase deficiency.

Authors:  J E Wraith
Journal:  Arch Dis Child       Date:  2001-01       Impact factor: 3.791

Review 2.  Recent advances in pediatric liver transplantation.

Authors:  Debora Kogan-Liberman; Sukru Emre; Benjamin L Shneider
Journal:  Curr Gastroenterol Rep       Date:  2002-02

Review 3.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

4.  Early orthotopic liver transplantation in urea cycle defects: follow up of a developmental outcome study.

Authors:  Philippe M Campeau; Penelope J Pivalizza; Geoffrey Miller; Kim McBride; Saul Karpen; John Goss; Brendan H Lee
Journal:  Mol Genet Metab       Date:  2010-02-19       Impact factor: 4.797

Review 5.  [Consensus on diagnosis and treatment of ornithine trans-carbamylase deficiency].

Authors: 
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-10-25

Review 6.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

Review 7.  Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.

Authors:  Mahsa Ghasemzad; Mahdieh Hashemi; Zohre Miri Lavasani; Nikoo Hossein-Khannazer; Haleh Bakhshandeh; Roberto Gramignoli; Hani Keshavarz Alikhani; Mustapha Najimi; Saman Nikeghbalian; Massoud Vosough
Journal:  Bioengineering (Basel)       Date:  2022-08-15

Review 8.  Liver transplantation in rare late-onset ornithine transcarbamylase deficiency with central nervous system injury: A case report and review of the literature.

Authors:  Xin Jin; Xinchen Zeng; Dong Zhao; Nan Jiang
Journal:  Brain Behav       Date:  2022-09-20       Impact factor: 3.405

9.  Fatal coma in a young adult due to late-onset urea cycle deficiency presenting with a prolonged seizure: a case report.

Authors:  Majid Alameri; Mustafa Shakra; Taoufik Alsaadi
Journal:  J Med Case Rep       Date:  2015-11-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.